nobiletin has been researched along with Cardiomegaly in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Che, Y; Deng, W; Jin, YG; Liao, HH; Tang, QZ; Wang, SS; Wei, WY; Yang, Z; Zhang, N | 1 |
Addepalli, V; Bhatt, LK; Parkar, NA | 1 |
2 other study(ies) available for nobiletin and Cardiomegaly
Article | Year |
---|---|
Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.
Topics: Animals; Antioxidants; Aorta; Body Weight; Cardiomegaly; Cardiotonic Agents; Disease Progression; Drug Administration Schedule; Endoplasmic Reticulum Stress; Flavones; Gene Expression; Heart; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Organ Size; Oxidative Stress; Phenylephrine; Primary Cell Culture | 2017 |
Efficacy of nobiletin, a citrus flavonoid, in the treatment of the cardiovascular dysfunction of diabetes in rats.
Topics: Acetylcholine; Animals; Antioxidants; Biomarkers; Cardiomegaly; Citrus; Diabetes Mellitus, Experimental; Flavones; Flavonoids; Hemodynamics; Hyperglycemia; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Oxidative Stress; Phenylephrine; Rats; Rats, Wistar | 2016 |